Categories
Recent Posts
- CV6 Therapeutics Secures $9.2m to Progress Novel Cancer Drug to Phase 1a Trial
- CV6 Therapeutics Featured in the NI Edition of the 12 Clusters of Tech
- CV6 Therapeutics Inc Recognised as a Platinum Level Innovator
- CV6 CEO Invited to Participate in Leading Biotech Europe CEO Event
- CV6 CEO to Present at Biotech Showcase™ 2019 in San Francisco